Homenuplazid

  • New dose formulation for Nuplazid, in Parkinsons, approved by FDA

    • July 1, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • ACADIA Pharmaceuticals reaffirms Nuplazid’s Benefit/Risk Profile

    • April 28, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • FDA re-examining safety of Nuplazid post reports of spike in adverse event

    • April 27, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more